Table 1 Tabular summary of the patient cohort and associated data. ‘Monitored’ and ‘Recorded’ denote the duration spanned by data and length continuous data contents, respectively, in hours. P:F ratio is the PaO2/FiO2 ratio at admission used to qualify ARDS and need for MV, AA African–American, AI American–Indian, AK Alaska, NMB neuromuscular blockade.
Detail | Count | \(\%\) | Median | IQR |
|---|---|---|---|---|
Monitored (h) | 47.1 | 38.2 | ||
Recorded (h) | 43.7 | 39 | ||
Age (years) | 58.0 | 24.8 | ||
Gender | ||||
Female | 14 | 40 | 54.5 | 25.0 |
Male | 21 | 60 | 58.0 | 26.5 |
Race/ethicity | ||||
White | 25 | 71.4 | ||
Unknown/NA | 5 | 14.3 | ||
Black/AA | 3 | 8.6 | ||
AI or AK native | 1 | 2.9 | ||
More than one race | 1 | 2.9 | ||
ARDS risk | ||||
Pneumonia | 11 | 31.4 | ||
COVID | 11 | 31.4 | ||
Sepsis | 6 | 17.1 | ||
Other | 3 | 8.6 | ||
Pancreatitis | 2 | 5.7 | ||
Aspiration | 2 | 5.7 | ||
P:F ratio | 136.0 | 77.0 | ||
Mortality | 8 | 22.9 | ||
NMB use | 9 | 25.7 |